Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy

Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy

Abstract Background Acute myeloid leukemia (AML) with myelodysplasia‐related characteristics is a heterogeneous subset of AML that has been challenged throughout the history of myeloid malignancies classifications, considered to have similar outcomes as intermediate‐ or adverse‐risk AML depending on...

Full description

Bibliographic Details
Main Authors: Harmony Leroy, Noémie Gadaud, Emilie Bérard, Emilie Klein, Isabelle Luquet, Jean‐Philippe Vial, Jean‐Baptiste Rieu, Nicolas Lechevalier, Suzanne Tavitian, Thibaut Leguay, Laetitia Largeaud, Audrey Bidet, Eric Delabesse, Audrey Sarry, Anne‐Charlotte deGrande, Christian Récher, Arnaud Pigneux, Sarah Bertoli, Pierre‐Yves Dumas
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Cancer Medicine
Subjects:
acute myeloid leukemia
azacitidine
intensive chemotherapy
myelodysplasia‐related changes
primary induction failure
refractoriness
Online Access:https://doi.org/10.1002/cam4.7003

Similar Items

Similar Items